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ABSTRACT  
INTRODUCTION: Diphtheria had been a major of cause of childhood mortality until the advent of an effective vaccine. 
Even in Nigeria with low to moderate coverage with the third dose of DPT the number of reported cases of diphtheria had 
been reducing. However, in a recent report we noted an increase in the incidence of diphtheria. The mainstay of 
management of diphtheria is the Diphtheria antitoxin. Diphtheria antitoxin is not available in Nigeria. We present the 
mortalities from diphtheria to highlight the need to stock the diphtheria antitoxin. 
METHODOLOGY: A review of the case notes of patients managed for diphtheria between August 2008 and 2010 was done 
and relevant data extracted. 
RESULTS: Nine cases of diphtheria were seen and three mortalities were recorded giving a mortality rate of 33.3%. One of 
the deaths was from myocardial involvement and acute renal failure while another was from possible septicaemia. The 
third mortality occurred at home after discharge from hospital 
DISCUSSION: Most of the symptoms of diphtheria are due to the effects of the diphtheria exotoxin. The non availability of 
the antitoxin for the management of these children contributed to their mortality. 
CONCLUSION: As long as diphtheria remains uneradicated the need for the antitoxin is imperative. 
 
INTRODUCTION 
Diphtheria, a disease caused by Corynebacterium 
diphtheria and its exotoxin is characterised by high 
case fatality (1-3). Diphtheria commonly affects the 
tonsils, pharynx and larynx. The C. diphtheria 
remains in the superficial mucosa or skin and 
elaborates its exotoxin. The diphtheria exotoxin, a 
potent 62 kd polypeptide inhibits protein synthesis 
leading to local tissue necrosis (2). The exotoxin is 
absorbed into the mucous membranes and causes 
destruction of epithelium and a superficial 
inflammatory response (3). The necrotic epithelium 
becomes embedded in exuding fibrin and red and 
white cells, resulting in a dense necrotic coagulum 
of organisms, epithelial cells, fibrin, leukocytes, and 
erythrocytes (3,4). This advances  – commonly over 
the tonsils, pharynx, or larynx, and becomes a gray-
brown, leather-like adherent pseudomembrane 
(Diphtheria is Greek for leather). With increase in the 
concentration of toxin, it is spread to other tissues 
through haematogenous dissemination (2). 
 
Laryngeal involvement, which may occur on its 
own or as a result of membrane extension from the 
nasopharynx, presents as hoarseness, stridor, 
croupy cough and dyspnea (3). These patients are at 
significant risk for suffocation because of local soft 
tissue edema and airway obstruction by the 
diphtheritic membrane (3). 
There may be toxin-mediated paralysis of soft 
palate, posterior oropharynx and hypopharynx (4). 




myocardium and peripheral nerves are most 
affected.2Other toxin mediated complications of 
diphtheria are toxic cardiomyopathy which occurs 
in 10–25% of patients with respiratory diphtheria 
and is responsible for 50–60% of deaths (3). 
Neurotoxicity and renal damage can also occur. 
Some of these features may present up to six weeks 
after the onset of the illness suggesting an 
immunological basis for the pathophysiologic 
mechanism for these delayed features of diphtheria 
(2). 
 
The mainstay of management of diphtheria is the 
antitoxin.   WHO (5) recommends immediate 
administration of diphtheria antitoxin and 
antibiotics following clinical diagnosis. The 
diphtheria vaccine is one of the major approaches 
for the control and prevention of diphtheria. In the 
pre-vaccine era diphtheria was common place with 
annual reported cases of 125,000 and 10,000 annual 
deaths from diphtheria being reported in the United 
States of America (3). With the advent of an 
effective vaccine against diphtheria and following 
the introduction of mass immunization the 
incidence of diphtheria fell to such levels that at the 
beginning of the 1980s many countries in the world 
were progressing toward the elimination of 
diphtheria (6). It in fact became a medical rarity (3). 
This was until the striking resurgence of diphtheria 
in the Newly Independent States (6). 
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The numbers of reported cases of diphtheria in 
Nigeria have been declining. Reported cases from 
Nigeria were 5,039 in 1989, 3,995 in 2000, 2,468 in 
2001, 790 in 2002 and 312 in 2006 (7). Immunization 
coverage with three doses of DPT in Nigeria has 
been inconsistent reaching an all time low in 2003 
(8). Current DPT 3 coverage in Nigeria is 72% (7). 
There are few reports on clinical diphtheria in 
Nigeria but most of these are old reports 
corroborating the possible declining prevalence of 
diphtheria in Nigeria. However, we reported 5 cases 
over a one year period in 2009 with 40% mortality 
and speculated on the possible resurgence of the 
disease (9). 
In this report we note the continued presence of 
cases suggesting the possible veracity of resurgence 
of the disease in Nigeria. The focus of this report 
however, are the mortalities recorded among the 
cases of diphtheria between 2008 and 2010 with a 
discussion on the need to stock the diphtheria 
antitoxin which is the mainstay of management of 
diphtheria. 
 
MATERIALS AND METHODS 
Records of patients managed for diphtheria over the 
period 2008 and 2010 in the University of Benin 
Teaching Hospital, Benin City were reviewed. In all 
cases diagnosis was clinical and confirmed 
microbiologically. The relevant clinical data were 
extracted. Each child received intravenous 
crystalline penicillin once the diagnosis was made 
or strongly suspected. Resection of the 
pseudomembrane was done in two children both of 
whom eventually required tracheostomy. No child 
received the diphtheria antitoxin as this is not 
available in Nigeria. The public health unit 
investigated each case and reported the cases to the 
appropriate authorities. Family and close contacts 
were treated with erythromycin while 
unimmunized children were immunized 
  
RESULTS 
Nine patients were admitted over the two year 
period. Their ages ranged 11 months to 10 years 
with a mean of 5.8±3.5 years. There were 4(44.4%) 
males and 5(55.6%) females. Three mortalities were 
recorded giving a mortality rate of 33.3%. The three 
deaths were one male infant (11months old) and 
two females aged 8 and 10 years. All three 
mortalities presented with fever, 
dysphagia/drooling of saliva and enlarged cervical 
lymph nodes. Other clinical features are as shown in 
table 1.  
 
Case A in addition to the features in table 1 had had 
measles two weeks prior to the onset of 
pharyngotonsillar symptoms. In fact he did not 
recover from the measles as he continued to have 
fever before the onset of the pharyngotonsillar 
symptoms. He also had visited a traditional healer 
who had made scarifications on his abdomen. 
Although he had been seen earlier in the General 
Practice Clinic of the hospital diphtheria was not 
suspected until he presented in the children’s 




TABLE 1: CLINICAL FEATURES OF CHILDREN  
WHO DIED FROM DIPHTHERIA 
 
Clinical features              Individual  cases  of diphtheria 
                                               a                        b                  c 
age                                      11mth              8yrs              10yrs                                      
sex                                        male              female         female                                       
fever                                       +                         +                    +                                      
cough                                     +                          -                    +                                                
nasal discharge                    +                         +                    -                                                
nausea/vomiting                  +                          -                    -                                     
diarrhea                                 +                         -                    -                                             
dysphagia/drooling/ 
inability to suck               +                      +                   +                                             
*duration of symptoms 
( in days)                                 2                         3                  4 
neck swelling/enlarged 
lymph nodes                          +                        +                   +                                          
enlarged tonsils                   +                       +                   -                                               
membrane on tonsils            -                        +                   +                                             
im status                            dpt2         ?complete       complete                                       
contact**                                 -                       -                     -                                                        
mother’s loe                         pry                     ?                  pry                                        
                    
 
+  attribute present    -  attribute absent    
im – immunization status * symptoms of pharyngtonsilar 
disease  
**contact with a case of diphtheria   loe – level of education     
 
pry – primary   dpt – diphtheria, petussis, tetanus vaccine  
 
 
Even so the initial diagnosis was septicaemia. He 
developed severe anaemia for which he was 
transfused. Thereafter he started bleeding from the 
nostrils and rapidly deteriorated and died. 
 
Case B improved following treatment and was 
discharged home after a week on admission. She 
developed nasal speech and regurgitation of water 
one week after discharge and died at home four 
days later 
 
Case C in addition to the features in table 1 
developed bradycardia and hypotension two days 
after admission. Electrocardiogram showed 
abnormalities of the ST segment. She was adjudged 
to have toxic cardiomyopathy and managed with 
fluids (including blood transfusion) and dopamine 
infusion. She subsequently developed acute renal 
failure with pulmonary oedema and died  
DISCUSSION 
The major features of morbidity resulting from 
diphtheria are from the exotoxin and once bound is 
not amenable to treatment. It is thus imperative that 
antitoxin is available for the management of cases of 
diphtheria. In fact, it is recommended that antitoxin 
be administered once diphtheria is suspected(3, 10).  
Worsening outcomes have been associated with 
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delays in administration of the antitoxin (2).  The 
antitoxin has been recommended to be given at an 
empirical dose based on the degree of toxicity, site 
and size of the membrane, and duration of illness 
(2).   Similar doses are given to adults and children 
(3).  The intravenous route is preferred (2).   
 
Diphtheria is associated with high mortality and 
one of the prognostic factors is the speed with 
which the antitoxin is administered (2).   For those in 
whom the disease is recognized on the first day and 
appropriate treatment instituted mortality is 1% but 
those in whom such treatment is delayed till the 
fourth day mortality rises to 20%.2The high 
mortality rate recorded in this series may have been 
due to the lack of antitoxin. The high mortality 
recorded in this series is similar to that reported 
from India in which a case fatality rate of 30.8% was 
recorded during an outbreak of diphtheria in which 
none of the patients benefited from antitoxin since 
none was available (11).   
The role of antimicrobial therapy in diphtheria is to 
halt toxin production, treat localized infection and 
prevent transmission of the organism to contacts (2, 
3).  Delay in making the diagnosis occasioned by 
late presentation of patients and a low index of 
suspicion in the first mortality in this series may 
also have contributed to the high mortality 
recorded. Delays allow time for multiplication of 
the organism and elaboration of toxins before the 
administration of effective antibiotics. Bound toxin 
is not amenable to treatment and in this series even 
the unbound toxin could not have been treated as 
there was no antitoxin. In a series reported from 
Thailand, early recognition and prompt treatment 
reportedly decreased complications and mortality 
(12).   
 
Early recognition of diphtheria is dependent on a 
high index of suspicion of the attending physician 
as there are other common causes of 
pharyngotonsillar disease such as exudative 
pharyngitis due to streptococcus pyogenes and 
Epstein-Barr virus, Vincent’s angina, bacterial 
epiglottitis, severe laryngotracheobronchitis, 
staphylococcal or streptococcal tracheitis.3 Since 
diphtheria had hitherto become uncommon it is 
necessary for practicing medical personnel to be 
reminded of diphtheria through continuing medical 
education programmes. Caregivers also need to be 
sensitized concerning diphtheria to improve care 
seeking behaviour. 
 
Rarely diphtheria may result in septicaemia with 
uniformly fatal outcome (2). While this is a 
possibility in the first mortality it was not confirmed 
by a positive blood culture. The possibility of 
septicaemia in this child is also likely given the fact 
that he had suffered from measles which is known 
to impair immunity and the causative organism 
may not necessarily be Corynebacterium diphtheria 
since he had scarification marks which may have 
served as portal of entry for other organisms. 
 
Some of the complications of diphtheria can occur 
as late as six weeks after the illness (2, 3).   Thus in 
the second case death occurred after the child had 
been discharged home in the third week of the 
illness. Although the history suggested that the 
child had neurological complications as evidenced 
by the nasal speech and the regurgitation of water, 
it is possible that the child may have had other more 
life threatening complications such as myocarditis. 
Complete recovery is often the expected outcome 
for neurological complications of diphtheria 
however in a series from India fatal aspiration led to 
mortality in a minority of cases with palatal 
paralysis (13).   In the same series poor outcome was 
associated with delay in instituting diphtheria 
antitoxin. Since a post mortem examination was not 
done in the current case it is not possible to state the 
definitive cause of death. It can however be 
speculated that if the child had received antitoxin 
the outcome may have been different. 
 
Early complication of the illness with myocardial 
disease has been associated with high mortality as 
was the case with the third mortality (3).  The 
additional complication of acute renal failure may 
have been due to the effect of the toxin. It could also 
have resulted from the repeated episodes of 
cardiogenic shock with resultant hypoperfusion of 
the kidneys. 
 
In developed countries such as the United States 
where diphtheria is all but a medical rarity the 
antitoxin is still stocked at Centre for Disease 
Control (CDC) and can be obtained within 24hours. 
While prevention by effective vaccination remains 
the best option, until the disease is eradicated the 
antitoxin should be available. 
 
Two of the three mortalities occurred in older 
children one of whom is said to have had complete 
immunization in infancy. It has been documented 
that the level of immunity wanes with time such 
that booster doses of DPT are required (14).  This 
becomes more pertinent in the face of improving 
social environments with fewer opportunities for 
cutaneous diphtheria which is believed to serve as 
boosters in developing countries. Research is 
needed to determine the levels of immunity in 
Nigerian children to guide policy decisions on the 
need for booster doses for diphtheria.Of importance 
is the need to strengthen the immunization 
programme. One of the mortalities had received 
only two doses of DPT and had not received 
measles vaccine despite being 11months old. He 
suffered measles prior to developing diphtheria a 




In conclusion Diphtheria would seem to be increasing 
in incidence in Nigeria. There is therefore a need to 
strengthen the immunization services as a means of 
prevention. However, as long as Diphtheria is not 
eradicated Diphtheria antitoxin should be available to 
treat clinical cases of diphtheria so as to reduce case 
fatality rates. The presence of diphtheria in any given 
community remains a potential risk for the rest of the 
world since the world has become a global village. 
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